NRC Health Announces Fourth Quarter 2025 Results

About this update from Nrc Health

[{"type":"text","content":"Fourth quarter TRCV* increased 8% year-over-year to $144.1 million","length":66,"tagName":"p","attribs":{}},{"type":"text","content":"Cash flow from operations increased 13% year-over-year to $7.2 million","length":70,"tagName":"p","attribs":{}},{"type":"text","content":"LINCOLN, Neb., February 03, 2026--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the fourth quarter 2025.","length":222,"tagName":"p"},{"type":"text","content":""Our fourth quarter results reflect the strong, disciplined execution happening across NRC Health and the deep trust our customers place in us," said Trent Green, CEO of NRC Health. "With TRCV reaching $144 million and momentum building across our portfolio, we finished the year with a strong foundation for continued execution. As healthcare leaders navigate unprecedented complexity, our mission—turning human understanding into meaningful, measurable action—has never been more essential. I’m incredibly proud of our teams and energized by the opportunity ahead as we continue helping our partners elevate the experiences of the people they serve."","length":672,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2025 Highlights","length":30,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue: Total revenue was $35.2 million for the three months ended December 31, 2025, up 2% quarter-over-quarter","length":113,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net Income: GAAP net income was $1.8 million, representing 5% of revenue, and Adjusted Net Income* was $3.4 million, representing 10% of revenue","length":144,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted EBITDA: Adjusted EBITDA* was $8.7 million, representing 25% of revenue","length":79,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Earnings Per Share: GAAP net income per fully diluted share was $0.08 on 21.8 million fully diluted shares; Adjusted net income per diluted share* was $0.16 on 21.8 million fully diluted shares","length":193,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Cash Flow: Net cash from operating activities was $7.2 million, representing 20% of revenue","length":91,"tagName":"p","attribs":{}...

More updates from Nrc Health